(Q37845909)

24 August 2017

1 reference

title

New aspects of drug-induced hypersensitivity syndrome (English)

1 reference

24 August 2017

Mikiko Tohyama

1

1 reference

24 August 2017

Koji Hashimoto

series ordinal

2

1 reference

24 August 2017

publication date

1 March 2011

1 reference

The Journal of Dermatology

24 August 2017

published in

1 reference

24 August 2017

volume

38

1 reference

24 August 2017

issue

3

1 reference

24 August 2017

page(s)

222-228

1 reference

The diagnosis of a DRESS syndrome has been sufficiently established on the basis of typical clinical features and viral reactivations.

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1346-8138.2010.01176.X

Association of human herpesvirus 6 reactivation with the flaring and severity of drug-induced hypersensitivity syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1346-8138.2010.01176.X

Several herpesviruses can reactivate in a severe drug-induced multiorgan reaction in the same sequential order as in graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1346-8138.2010.01176.X

Reactivation of human herpesvirus (HHV) family members other than HHV-6 in drug-induced hypersensitivity syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1346-8138.2010.01176.X

Drug-induced hypersensitivity syndrome due to mexiletine associated with human herpes virus 6 and cytomegalovirus reactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1346-8138.2010.01176.X

Cytomegalovirus disease during severe drug eruptions: report of 2 cases and retrospective study of 18 patients with drug-induced hypersensitivity syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1346-8138.2010.01176.X

Toxic epidermal necrolysis due to zonisamide associated with reactivation of human herpesvirus 6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1346-8138.2010.01176.X

Analysis of Stevens-Johnson syndrome and toxic epidermal necrolysis in Japan from 2000 to 2006.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1346-8138.2010.01176.X

Drug reaction with eosinophilia and systemic symptoms (DRESS): a multiorgan antiviral T cell response

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1346-8138.2010.01176.X

Drug-induced pseudolymphoma and drug hypersensitivity syndrome (Drug Rash with Eosinophilia and Systemic Symptoms: DRESS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1346-8138.2010.01176.X

Drug-induced hypersensitivity syndrome associated with cytomegalovirus reactivation: immunological characterization of pathogenic T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1346-8138.2010.01176.X

Frequent isolation of HHV-6 from saliva and high seroprevalence of the virus in the population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1346-8138.2010.01176.X

Emergence of circulating monomyeloid precursors predicts reactivation of human herpesvirus-6 in drug-induced hypersensitivity syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1346-8138.2010.01176.X

Clinical outcomes of human herpesvirus 6 reactivation after hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1346-8138.2010.01176.X

Correlation between HHV-6 infection and skin rash after allogeneic bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1346-8138.2010.01176.X

Relationship among human herpesvirus 6 reactivation, serum interleukin 10 levels, and rash/graft-versus-host disease after allogeneic stem cell transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1346-8138.2010.01176.X

Association between anticonvulsant hypersensitivity syndrome and human herpesvirus 6 reactivation and hypogammaglobulinemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1346-8138.2010.01176.X

Defective regulatory T cells in patients with severe drug eruptions: timing of the dysfunction is associated with the pathological phenotype and outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1346-8138.2010.01176.X

The nature of the principal type 1 interferon-producing cells in human blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1346-8138.2010.01176.X

Plasmacytoid dendritic cells in immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1346-8138.2010.01176.X

10.1111/J.1346-8138.2010.01176.X

21 January 2018

Identifiers

DOI

1 reference

24 August 2017

1 reference